chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching; itching; swelling; swelling; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VACCINATION SITE PRURITUS (itching), the second episode of VACCINATION SITE PRURITUS (itching), the first episode of VACCINATION SITE SWELLING (swelling) and the second episode of VACCINATION SITE SWELLING (swelling) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced the first episode of VACCINATION SITE SWELLING (swelling). On 03-Feb-2021, the patient experienced the first episode of VACCINATION SITE PRURITUS (itching), the second episode of VACCINATION SITE PRURITUS (itching) and the second episode of VACCINATION SITE SWELLING (swelling). At the time of the report, last episode of VACCINATION SITE PRURITUS (itching) and the last episode of VACCINATION SITE SWELLING (swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Chills; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation and Cholesterol. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.  On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medications include blood pressure pills and cholesterol medicine.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068391 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068391:Patient first dose case
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood pressure increased, Contusion, Headache
Clinical narrative: splitting headache for several hours; blood pressure shot sky high; left arm still bruised size of a marble; high sugar levels; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (splitting headache for several hours), BLOOD PRESSURE INCREASED (blood pressure shot sky high), CONTUSION (left arm still bruised size of a marble) and BLOOD GLUCOSE INCREASED (high sugar levels) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetic.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HEADACHE (splitting headache for several hours), BLOOD PRESSURE INCREASED (blood pressure shot sky high), CONTUSION (left arm still bruised size of a marble) and BLOOD GLUCOSE INCREASED (high sugar levels). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 15-Jan-2021, HEADACHE (splitting headache for several hours), BLOOD PRESSURE INCREASED (blood pressure shot sky high) and BLOOD GLUCOSE INCREASED (high sugar levels) had resolved. At the time of the report, CONTUSION (left arm still bruised size of a marble) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The patient added that her blood pressure hit 204/96 for about 3-4 hours and then went back to 170/70 something. She always specified about her sugar levels that she had 117 or 98 or 124 but never had them go over 441 or 444 like at the time of the report. She stated she felt like her brain was hot.   No concomitant medications were reported.  Treatment of the event included Tylenol.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased
Clinical narrative: My Blood Pressure shot up about 40 points; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (My Blood Pressure shot up about 40 points) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, LEVOTHYROXINE, FOLIC ACID, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), Orencia Weekly Injection, TEMAZEPAM and IBUPROFEN for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (My Blood Pressure shot up about 40 points). At the time of the report, BLOOD PRESSURE INCREASED (My Blood Pressure shot up about 40 points) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medications included Blood pressure medication.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vomiting
Clinical narrative: Headache; Chills; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine headache.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (vomiting). At the time of the report, HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (vomiting) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were provided by the reporter.  No treatment medication was reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at the injection site) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site). At the time of the report, VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were unknown.  Treatment for the event is unknown.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up includes updated email address. Non-significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: arm is really sore; hands were swollen, real tight; fever; vomiting; a little bit of a cough; hurt all over; has a really bad spot where she got the shot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough) and PAIN (hurt all over) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03/L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough), PAIN (hurt all over) and RASH MACULAR (has a really bad spot where she got the shot). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm is really sore). On 25-Feb-2021, PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough) and PAIN (hurt all over) had resolved. At the time of the report, RASH MACULAR (has a really bad spot where she got the shot) and PAIN IN EXTREMITY (arm is really sore) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vomiting
Clinical narrative: arm is really sore; hands were swollen, real tight; fever; vomiting; a little bit of a cough; hurt all over; has a really bad spot where she got the shot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough) and PAIN (hurt all over) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03/L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough), PAIN (hurt all over) and RASH MACULAR (has a really bad spot where she got the shot). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm is really sore). On 25-Feb-2021, PERIPHERAL SWELLING (hands were swollen, real tight), PYREXIA (fever), VOMITING (vomiting), COUGH (a little bit of a cough) and PAIN (hurt all over) had resolved. At the time of the report, RASH MACULAR (has a really bad spot where she got the shot) and PAIN IN EXTREMITY (arm is really sore) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: nausea; headache; body aches; 99.4 F fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included INTERFERON BETA-1A (AVONEX) for an unknown indication.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever). At the time of the report, NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches) and PYREXIA (99.4 F fever) outcome was unknown. Not Provided    No treatment information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Rash macular
Clinical narrative: big red spot; doesn't hurt badly only had little achiness; all red (right arm); felt warm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (all red (right arm)), INJECTION SITE WARMTH (felt warm), RASH MACULAR (big red spot) and INJECTION SITE PAIN (doesn't hurt badly only had little achiness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (all red (right arm)) and INJECTION SITE WARMTH (felt warm). On an unknown date, the patient experienced RASH MACULAR (big red spot) and INJECTION SITE PAIN (doesn't hurt badly only had little achiness). At the time of the report, INJECTION SITE ERYTHEMA (all red (right arm)), INJECTION SITE WARMTH (felt warm), RASH MACULAR (big red spot) and INJECTION SITE PAIN (doesn't hurt badly only had little achiness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications reported were medication for condition of her heart for many years.  No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Vaccination site erythema
Clinical narrative: hot red rash all over body; rash raised; Red mark on arm below injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (hot red rash all over body), RASH (rash raised) and VACCINATION SITE ERYTHEMA (Red mark on arm below injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (hot red rash all over body), RASH (rash raised) and VACCINATION SITE ERYTHEMA (Red mark on arm below injection site). At the time of the report, RASH ERYTHEMATOUS (hot red rash all over body), RASH (rash raised) and VACCINATION SITE ERYTHEMA (Red mark on arm below injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: fever up to 100.4 F; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever up to 100.4 F) and MYALGIA (body aches) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (chills). On 04-Feb-2021, the patient experienced PYREXIA (fever up to 100.4 F) and MYALGIA (body aches). On 03-Feb-2021, CHILLS (chills) had resolved. At the time of the report, PYREXIA (fever up to 100.4 F) and MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 100.4 (High) 100.4 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment details were not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Erythema, Rash
Clinical narrative: Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?; little red pimples; little red pimples; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?), ACNE (little red pimples) and ERYTHEMA (little red pimples) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced ACNE (little red pimples) and ERYTHEMA (little red pimples). On 05-Feb-2021, the patient experienced RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?). At the time of the report, RASH (Reports having a localized rash in lower torso/belly that is stretching to sides a bit. Patient describes appearance as "little red dots". Is there anything about rashes?), ACNE (little red pimples) and ERYTHEMA (little red pimples) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Epistaxis, Myalgia, Oropharyngeal pain, Vomiting
Clinical narrative: nose bleeds; diarrhea; muscle ache; body aches; sore throat; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches) and OROPHARYNGEAL PAIN (sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches), OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting). At the time of the report, EPISTAXIS (nose bleeds), DIARRHOEA (diarrhea), MYALGIA (muscle ache), MYALGIA (body aches), OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Her arm is itchy; Her arm is red, there is a red spot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot). At the time of the report, PRURITUS (Her arm is itchy) and ERYTHEMA (Her arm is red, there is a red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  The patient did not take any treatment medication.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Fatigue, Lymph node pain
Clinical narrative: Chills; Eye pain; sore lymph nodes on right neck; Fatigue; pain of lymph node on both arms; pain of lymph node on the neck; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), LYMPH NODE PAIN (pain of lymph node on both arms), LYMPH NODE PAIN (pain of lymph node on the neck), LYMPH NODE PAIN (sore lymph nodes on right neck) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (Fatigue), LYMPH NODE PAIN (pain of lymph node on both arms) and LYMPH NODE PAIN (pain of lymph node on the neck). On 22-Feb-2021, the patient experienced LYMPH NODE PAIN (sore lymph nodes on right neck) and EYE PAIN (Eye pain). On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, FATIGUE (Fatigue), LYMPH NODE PAIN (pain of lymph node on both arms), LYMPH NODE PAIN (pain of lymph node on the neck), LYMPH NODE PAIN (sore lymph nodes on right neck), CHILLS (Chills) and EYE PAIN (Eye pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain in extremity
Clinical narrative: Arm soreness; Dizziness; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), DIZZINESS (Dizziness), FATIGUE (Fatigue) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), DIZZINESS (Dizziness), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Arm soreness), DIZZINESS (Dizziness), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.            No concomitant medication was provided.  No treatment details were provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Slight Fever; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight Fever), HEADACHE (Headache) and FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (Slight Fever), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Slight Fever), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medication was provided.  No treatment details were provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia oral
Clinical narrative: Red face; Red neck; Tingling tongue; Tingling lips; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red face), ERYTHEMA (Red neck), PARAESTHESIA ORAL (Tingling tongue) and PARAESTHESIA ORAL (Tingling lips) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ERYTHEMA (Red face), ERYTHEMA (Red neck), PARAESTHESIA ORAL (Tingling tongue) and PARAESTHESIA ORAL (Tingling lips). At the time of the report, ERYTHEMA (Red face), ERYTHEMA (Red neck), PARAESTHESIA ORAL (Tingling tongue) and PARAESTHESIA ORAL (Tingling lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Neck pain, Vaccination site pain
Clinical narrative: sore neck; chills; sore shoulder where she received the injection; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (sore neck), CHILLS (chills) and VACCINATION SITE PAIN (sore shoulder where she received the injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL for an unknown indication.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced NECK PAIN (sore neck), CHILLS (chills) and VACCINATION SITE PAIN (sore shoulder where she received the injection). At the time of the report, NECK PAIN (sore neck), CHILLS (chills) and VACCINATION SITE PAIN (sore shoulder where she received the injection) outcome was unknown.            The patient received unspecified concomitant medications. The patient did not take any treatment medication.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache, Pain
Clinical narrative: Nagging headache; Body aches; Backache; Feels extremely tired; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), HEADACHE (Nagging headache), PAIN (Body aches), BACK PAIN (Backache) and FATIGUE (Feels extremely tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included High Blood Pressure Medication, Antihyperlipidemic, LEVOTHYROXINE, ESCITALOPRAM OXALATE (LEXAPRO), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), COLECALCIFEROL, UBIDECARENONE (CO-Q10+VITAMIN D3) and VITAMIN B COMPLEX for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced FATIGUE (Tiredness). On 24-Feb-2021, the patient experienced HEADACHE (Nagging headache), PAIN (Body aches), BACK PAIN (Backache) and FATIGUE (Feels extremely tired). At the time of the report, FATIGUE (Tiredness), HEADACHE (Nagging headache), PAIN (Body aches), BACK PAIN (Backache) and FATIGUE (Feels extremely tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchiness at the area of the injection; swelling at the area of the injection; redness at the area of the injection; burning at the area of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the area of the injection), VACCINATION SITE SWELLING (swelling at the area of the injection), VACCINATION SITE ERYTHEMA (redness at the area of the injection) and VACCINATION SITE PAIN (burning at the area of the injection) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the area of the injection), VACCINATION SITE SWELLING (swelling at the area of the injection), VACCINATION SITE ERYTHEMA (redness at the area of the injection) and VACCINATION SITE PAIN (burning at the area of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Vaccination site swelling, Vaccination site erythema, Vaccination site pruritus and Vaccination site burning, at a dose of UNK dosage form and PARACETAMOL (TYLENOL) for Vaccination site swelling, Vaccination site erythema, Vaccination site pruritus and Vaccination site burning, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (itchiness at the area of the injection), VACCINATION SITE SWELLING (swelling at the area of the injection) and VACCINATION SITE PAIN (burning at the area of the injection) outcome was unknown and VACCINATION SITE ERYTHEMA (redness at the area of the injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  The redness extended up to her shoulder and down to her elbow. The patient consulted her primary care physician who prescribed her with Benadryl Cream, Tylenol and advised her to apply cold compress on the area. The area of redness had decreased in size.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pallor, Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: 24Feb2021 the injection site is pale; Fatigue; injection site was warm; injection site was bright red; area swelled to the size of a Tennis Ball; soreness; hardness the size of a quarter at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALLOR (24Feb2021 the injection site is pale), VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site), VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red) and VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0161M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site) and VACCINATION SITE PAIN (soreness). On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red) and VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball). On 24-Feb-2021, the patient experienced PALLOR (24Feb2021 the injection site is pale) and FATIGUE (Fatigue). At the time of the report, PALLOR (24Feb2021 the injection site is pale), VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site), VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red), VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball), VACCINATION SITE PAIN (soreness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: 24Feb2021 the injection site is pale; Fatigue; injection site was warm; injection site was bright red; area swelled to the size of a Tennis Ball; soreness; hardness the size of a quarter at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALLOR (24Feb2021 the injection site is pale), VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site), VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red) and VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0161M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site) and VACCINATION SITE PAIN (soreness). On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red) and VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball). On 24-Feb-2021, the patient experienced PALLOR (24Feb2021 the injection site is pale) and FATIGUE (Fatigue). At the time of the report, PALLOR (24Feb2021 the injection site is pale), VACCINATION SITE INDURATION (hardness the size of a quarter at the injection site), VACCINATION SITE WARMTH (injection site was warm), VACCINATION SITE ERYTHEMA (injection site was bright red), VACCINATION SITE SWELLING (area swelled to the size of a Tennis Ball), VACCINATION SITE PAIN (soreness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (injection site feels warm), rash macular (bright red spot at injection site and it's spreading), vaccination site pain (soreness in arm) and vaccination site swelling (swelling at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 004M20A) for COVID-19 immunization. Concomitant products included temazepam and omeprazole for an unknown indication. On Jan 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 27, 2021, patient experienced vaccination site pain (soreness in arm). On Feb 3, 2021, patient experienced vaccination site warmth (injection site feels warm), rash macular (bright red spot at injection site and it's spreading) and vaccination site swelling (swelling at injection site). On Jan 28, 2021, vaccination site pain (soreness in arm) resolved. At the time of the report, vaccination site warmth (injection site feels warm), rash macular (bright red spot at injection site and it's spreading) and vaccination site swelling (swelling at injection site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No treatment information provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: shingles on face; Rash on his face; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles on face) and RASH (Rash on his face) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced HERPES ZOSTER (shingles on face) and RASH (Rash on his face). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles on face) and RASH (Rash on his face) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications reported.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Arms are getting sore, and pain has gone down to her legs.; feels tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Arms are getting sore, and pain has gone down to her legs.) and FATIGUE (feels tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Arms are getting sore, and pain has gone down to her legs.) and FATIGUE (feels tired). At the time of the report, PAIN (Arms are getting sore, and pain has gone down to her legs.) and FATIGUE (feels tired) outcome was unknown.            No concomitant medications reported. No treatment medications provided by the reporter.  Action taken with mRNA-1273 in response to events was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments    Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant follow up - AE contact details updated. Reported getting second dose on 16 MAR 2021.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue, Pruritus, Urticaria
Clinical narrative: 2nd dose was this past Sunday, but she did not want to receive it because of the cetirizine; Hives on abdomen and both arms; itching; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), URTICARIA (Hives on abdomen and both arms), PRURITUS (itching) and PRODUCT DOSE OMISSION ISSUE (2nd dose was this past Sunday, but she did not want to receive it because of the cetirizine) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 05-Jan-2021, the patient experienced URTICARIA (Hives on abdomen and both arms) and PRURITUS (itching). On 31-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose was this past Sunday, but she did not want to receive it because of the cetirizine). The patient was treated with CETIRIZINE for Pain in arm, Hives and Itching, at a dose of UNK dosage form. On 31-Jan-2021, PRODUCT DOSE OMISSION ISSUE (2nd dose was this past Sunday, but she did not want to receive it because of the cetirizine) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm pain) and PRURITUS (itching) outcome was unknown and URTICARIA (Hives on abdomen and both arms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Dehydration, Fatigue, Hypersomnia
Clinical narrative: experiencing symptoms exactly like covid symptoms; slept the day away; never ate or drank; lips was looking dehydrated; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020. Concomitant products included ATORVASTATIN, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), FINASTERIDE, LISINOPRIL, TAMSULOSIN and VALACYCLOVIR [VALACICLOVIR] for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired). At the time of the report, SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 100.2 (High) 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take any treatment.  The patient had COVID-19 in Oct-2020. It was 8 days prior to fulfilling the 3 month waiting period when he received the vaccine.  He was very ill with the covid symptoms for about 12 hours the next day. This happened for just one day. The patient did not take anything for his symptoms.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: experiencing symptoms exactly like covid symptoms; slept the day away; never ate or drank; lips was looking dehydrated; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020. Concomitant products included ATORVASTATIN, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), FINASTERIDE, LISINOPRIL, TAMSULOSIN and VALACYCLOVIR [VALACICLOVIR] for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired). At the time of the report, SUSPECTED COVID-19 (experiencing symptoms exactly like covid symptoms), HYPERSOMNIA (slept the day away), DECREASED APPETITE (never ate or drank), DEHYDRATION (lips was looking dehydrated) and FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 100.2 (High) 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take any treatment.  The patient had COVID-19 in Oct-2020. It was 8 days prior to fulfilling the 3 month waiting period when he received the vaccine.  He was very ill with the covid symptoms for about 12 hours the next day. This happened for just one day. The patient did not take anything for his symptoms.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: Arm swollen; Arm is hurting; Arm is warm to the touch; Arm is red down to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm swollen), PAIN IN EXTREMITY (Arm is hurting), FEELING HOT (Arm is warm to the touch) and ERYTHEMA (Arm is red down to the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Food poisoning
Clinical narrative: diarrhea/possible food poisoning; diarrhea/possible food poisoning; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning). At the time of the report, DIARRHOEA (diarrhea/possible food poisoning) and FOOD POISONING (diarrhea/possible food poisoning) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.